Tackling Anxiety-related Freezing of Gait in People With Parkinson's Disease Trial N/A Completed March 11, 2026
Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism Trial Phase 2 Completed March 11, 2026
Hypothalamic atrophy in progressive supranuclear palsy, assessed by convolutional neural network-based automatic segmentation. Research Journal of neurology March 11, 2026
Enhancing Adherence to Home-Based Expiratory Muscle Strength Training in Parkinson Disease: Randomized Controlled Trial of an mHealth Intervention. Research Journal of medical Internet research March 11, 2026
Low-Fidelity Driving Simulator Training in Parkinson's Disease. Trial N/A Not yet recruiting March 10, 2026
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study Trial N/A Recruiting March 10, 2026
Insights and priorities from the 2025 private funders’ Parkinson's disease and related disorders large footprint data interoperability summit News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents March 10, 2026
From General-Purpose to Disease-Specific Features: Aligning LLM Embeddings on a Disease-Specific Biomedical Knowledge Graph for Drug Repurposing. Research bioRxiv : the preprint server for biology March 10, 2026
Change in movement disorder specialist attitudes to genetic testing after implementation of PD GENEration. Research Genetics in medicine open March 10, 2026
Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease. Research Annals of clinical and translational neurology March 10, 2026
Plasma isomiRs as Candidate Biomarkers for Amyotrophic Lateral Sclerosis. Research Neurology. Genetics March 10, 2026
ASAH2 deficiency affects sphingolipid homeostasis and neuromotor control, causing a progressive neurological disorder. Research HGG advances March 10, 2026
Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. Trial Early Phase 1 Not yet recruiting March 9, 2026
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy Trial Phase 2 Active, not recruiting March 9, 2026
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG) Trial N/A Recruiting March 9, 2026